Rapid Dose Therapeutics Corp. announced another significant addition to the Company's advisory board with the appointment of Dr. Michael Glogauer. Dr. Glogauer is the Dentist in Chief at the University Health Network and Princess Margaret Cancer Centre and a Full Professor in the Faculty of Dentistry at the University of Toronto.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 CAD | 0.00% | +22.58% | +15.15% |
06-29 | Rapid Dose Therapeutics Corp. Reports Earnings Results for the Full Year Ended February 29, 2024 | CI |
05-29 | Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application | MT |
1st Jan change | Capi. | |
---|---|---|
+15.15% | 16.98M | |
+16.15% | 251M |
- Stock Market
- Equities
- DOSE Stock
- News Rapid Dose Therapeutics Corp.
- Rapid Dose Therapeutics Corp. Appoints Michael Glogauer to Advisory Board